Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)

SHE:300534 Revenue

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD had revenue of 100.81M CNY in the quarter ending June 30, 2026, a decrease of -51.25%. This brings the company's total for the last twelve months to 737.90M, down -24.96% year-over-year. In the year 2025, Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD had annual revenue of 886.96M, down -14.92%. That makes Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD the 21,877th largest company in the world by revenue and 4,000th in China.

• Revenue (ttm): 737.90M
• Revenue Growth: -24.96%
• P/S Ratio: 4.37
• Revenue / Employee: 1.11M
• Employees: 641
• Market Cap: 3.10B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 874.83M 98.6%
• Foreign 12.13M 1.4%

Fiscal year ended Dec 31, 2025 See the full SHE:300534 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	886.96M	-155.55M	-14.92%
Dec 31, 2024	1.04B	-37.54M	-3.48%
Dec 31, 2023	1.08B	280.37M	35.06%
Jan 1, 2023	799.68M	511.87M	177.85%
Jan 1, 2022	287.81M	32.91M	12.91%

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error